טוען...
Efficacy and safety of adalimumab in ankylosing spondylitis
Ankylosing spondylitis (AS) is the most common and most severe subtype of spondyloarthritis. It also may be an outcome of any of the other spondyloarthritis subtypes. AS preferentially affects the sacroiliac joints and the tip of the column, with a tendency to later ankylosis. Peripheral joints, ent...
שמור ב:
| הוצא לאור ב: | Open Access Rheumatol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045114/ https://ncbi.nlm.nih.gov/pubmed/27790037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S44550 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|